{
    "clinical_study": {
        "@rank": "109374", 
        "arm_group": {
            "arm_group_label": "Previous 18F-AV-1451 Scan", 
            "arm_group_type": "Experimental", 
            "description": "Subjects with a previous 18F-AV-1451 scan will receive an IV injection, 370  megabecquerel (MBq) (10 millicurie [mCi]), single dose of 18F-AV-1451. Subjects with an unknown amyloid status will receive an IV injection, 370 megabecquerel (MBq) (10 millicurie [mCi]), single dose of florbetapir F 18."
        }, 
        "brief_summary": {
            "textblock": "This study will evaluate the imaging characteristics of 18F-AV-1451 in subjects with a\n      previous 18F-AV-1451 scan in order to assess the rate of change of tau deposition over time."
        }, 
        "brief_title": "Imaging Characteristics of a Follow-up 18F-AV-1451 Scan", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Alzheimer's Disease", 
        "condition_browse": {
            "mesh_term": "Alzheimer Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Have a previous 18F-AV-1451 brain scan\n\n          -  Can tolerate up to two Positron Emission Tomography (PET) imaging sessions and a\n             Magnetic Resonance Imaging (MRI) scan\n\n          -  Ability to provide informed consent\n\n        Exclusion Criteria:\n\n          -  Current clinically significant psychiatric disease\n\n          -  Are claustrophobic\n\n          -  Current clinically significant cardiovascular disease or ECG abnormalities, or\n             additional risk factors for Torsades de Pointes\n\n          -  Current clinically significant infectious disease, endocrine or metabolic disease,\n             pulmonary, renal or hepatic impairment, or cancer\n\n          -  Females of childbearing potential who are not surgically sterile, not refraining from\n             sexual activity or not using reliable methods of contraception\n\n          -  Have had a non-study related radiopharmaceutical imaging or treatment procedure\n             within 7 days prior to the study imaging session"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02051764", 
            "org_study_id": "18F-AV-1451-A04"
        }, 
        "intervention": [
            {
                "arm_group_label": "Previous 18F-AV-1451 Scan", 
                "intervention_name": "18F-AV-1451", 
                "intervention_type": "Drug", 
                "other_name": "[F-18]T807"
            }, 
            {
                "arm_group_label": "Previous 18F-AV-1451 Scan", 
                "intervention_name": "Florbetapir F 18", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Amyvid", 
                    "18F-AV-45"
                ]
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 9, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Newport Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92663"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92868"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open Label, Multicenter Study, Evaluating the Imaging Characteristics of a Follow-up 18F-AV-1451 Scan in Subjects Who Have Had a Prior 18F-AV-1451 Scan", 
        "overall_contact": {
            "email": "clinicaloperations@avidrp.com", 
            "last_name": "Avid Clinical Operations", 
            "phone": "215-298-0700"
        }, 
        "overall_official": {
            "affiliation": "Avid Radiopharmaceuticals, Inc.", 
            "last_name": "Chief Medical Officer", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To assess the rate of change of tau deposition as measured by 18F-AV-1451 standard uptake value ratio (SUVr) over time.", 
            "measure": "Change in Tau deposition", 
            "safety_issue": "No", 
            "time_frame": "At least 6 months after initial 18F-AV-1451 scan"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02051764"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Avid Radiopharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Avid Radiopharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}